4.4 Article

Polymeric micelles for enhanced Photofrin II® delivery, cytotoxicity and pro-apoptotic activity in human breast and ovarian cancer cells

期刊

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
卷 11, 期 4, 页码 570-585

出版社

ELSEVIER
DOI: 10.1016/j.pdpdt.2014.10.005

关键词

Mixed Pluronic micelles; Photofrin II (R); Photodynamic therapy; Cancer cells; Release characteristics; Hemolytic activity

类别

资金

  1. Wroclaw Research Center EIT+ under the project 'Biotechnologies and advanced medical technologies' - BioMed - European Regional Development Fund Operational Programme Innovative Economy [POIG 01.01.02-02-003/08-00]
  2. Polish Ministry of Science and Higher Education for the Faculty of Chemistry of Wroclaw University of Technology

向作者/读者索取更多资源

Background: Searching for photodynamic therapy (PDT) - effective nanocarriers which enable a photosensitizer to be selectively delivered to tumor cells with enhanced bioavailability and diminished dark cytotoxicity is of current interest. The main objective of this study is to evaluate newly designed mixed polymeric micelles based on Pluronics P123 and F127 for the improved delivery of Photofrin II (R) (Ph II (R)) to circumvent unfavorable effects overcoming multidrug resistance (MDR) in tumor cells - in breast MCF-7/WT (caspase-3 deficient) and ovarian SKOV-3 (resistant to chemotherapy). Methods: Ph II (R)-loaded micelles were obtained and analyzed for size and morphology, solubilization efficiency, physical stability and in vitro drug release. Intracellular uptake, reactive oxygen species (ROS) generation, mitochondrial oxidoreductive potential and proapoptotic activity (TUNEL assay) studies were evaluated in the examined cancer cells. The preliminary biocompatibility characteristics of all nanocarriers was determined by assessment of their hemolytic activity in human erythrocytes and dark toxicity in cancer cells. Results: Dynamic light scattering (DLS) and atomic force microscopy (AFM) confirmed that almost monodisperse, sphere-shaped and nanosized (D-H < 20 nm) carriers were developed. Biological studies after photodynamic reaction (PDR) with encapsulated Ph II (R) revealed increased ROS level, malondialdehyde (MDA) concentration and protein damage in SKOV-3 and MCF-7/WT cells in comparison to treatment with free Ph II (R). Numerous apoptotic cells were detected after nano-therapy in both cell lines, with observed significant morphological disorders in ovarian cancer cells. In the case of encapsulated Ph II (R) only negligible disruption of human erythrocytes and cancer cells was observed. Conclusions: The obtained biocompatible long-lasting nanocarriers significantly enhance the Photofrin II (R) photodynamic effect and apoptosis in both SKOV-3 and MCF-7/WT cell lines. (C) 2014 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据